rtki cpd has been researched along with Carcinoma, Mucoepidermoid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hur, GY; In, KH; Jung, HC; Jung, KH; Kang, EJ; Kang, KH; Kim, JH; Lee, SY; Shim, JJ; Shin, C; Yoo, SH | 1 |
| Hegab, AE; Homma, S; Iizuka, T; Ishii, Y; Kiwamoto, T; Matsuno, Y; Morishima, Y; Nomura, A; Sakamoto, T; Sekizawa, K | 1 |
2 other study(ies) available for rtki cpd and Carcinoma, Mucoepidermoid
| Article | Year |
|---|---|
Peroxisome proliferator-activated receptor-gamma inhibits cigarette smoke solution-induced mucin production in human airway epithelial (NCI-H292) cells.
Topics: Carcinoma, Mucoepidermoid; Cell Line, Tumor; Down-Regulation; Enzyme Inhibitors; ErbB Receptors; Humans; Hypoglycemic Agents; Lung Neoplasms; Mucin 5AC; Mucins; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; PPAR gamma; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Quinazolines; Respiratory Mucosa; Rosiglitazone; Smoking; Thiazolidinediones; Tumor Necrosis Factor-alpha; Tyrosine; Tyrphostins | 2006 |
Niflumic acid and AG-1478 reduce cigarette smoke-induced mucin synthesis: the role of hCLCA1.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Bronchi; Bronchial Neoplasms; Carcinoma, Mucoepidermoid; Cell Line, Tumor; Chloride Channels; ErbB Receptors; Gene Expression; Humans; Male; Mucin 5AC; Mucins; Niflumic Acid; Protein Tyrosine Phosphatases; Quinazolines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Smoking; Tyrphostins | 2007 |